On this page
Bio-Synergy targets £3-5 million in first-year India sales with DNA + Epigenetics testing kit launch
Our read
Bio-Synergy is more likely to fall short of its £3-5 million first-year India target on the kit alone than to hit it, and it will probably lean on supplement cross-sell and wider distribution to close the gap.
For operators
Bio-Synergy is selling its DNA + Epigenetics Kit at ₹25,000 to ₹85,000 only through its own website for now, so supplement and wellness retailers should prepare for wider availability by end of October and decide whether to stock it or partner.
Watch
Announcement of new retail, clinic or e-commerce channels by end of October
The report,
Bio-Synergy launched the kit in Mumbai with partner Kynora Life Sciences LLP, with packages priced between ₹25,000 and ₹85,000. The packages will be sold directly through its website.
- First-year India sales target
- £3-5 million
- Kit price range
- ₹25,000 to ₹85,000
- Kynora reach target during FY28
- 10,000 people
Reported figures
From the report. Source details below
| Kynora reach target during FY28: | 10,000 people |
|---|---|
| India supplements market size: | ₹8,000 crore |
| India supplements category annual growth: | 14 per cent |
What to track next
- Any first-year sales update against the £3-5 million target
- Launch of cheaper or entry-level packages below ₹25,000
- Rival genomics or supplement brands launching comparable DNA or epigenetics products in India
- Regulatory notices, advisories or media scrutiny on genetic testing claims or data privacy